A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis
- Author
- AKPEK, Esen Karamursel1 ; DART, John K2 ; WATSON, Stephanie2 ; CHRISTEN, William3 ; DURSUN, Dilek4 ; YOO, Sonia4 ; O'BRIEN, Terrence P1 ; SCHEIN, Oliver D1 ; GOTTSCH, John D1
[1] The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
[2] Moorfields Eye Hospital, London, United Kingdom
[3] Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States
[4] Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States - Source
Ophthalmology (Rochester, MN). 2004, Vol 111, Num 3, pp 476-482, 7 p ; ref : 25 ref
- CODEN
- OPHTDG
- ISSN
- 0161-6420
- Scientific domain
- Ophthalmology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Atopie Chimiothérapie Ciclosporine Efficacité traitement Homme Kératoconjonctivite Randomisation Résistance traitement Stéroïde Voie locale Allergie Conjonctive pathologie Immunopathologie Kératopathie Oeil pathologie Segment antérieur pathologie
- Keyword (en)
- Atopy Chemotherapy Ciclosporin Treatment efficiency Human Keratoconjunctivitis Randomization Treatment resistance Steroid Local administration Allergy Conjunctiva disease Immunopathology Keratopathy Eye disease Anterior segment disease
- Keyword (es)
- Atopía Quimioterapia Ciclosporina Eficacia tratamiento Hombre Queratoconjuntivitis Aleatorización Resistencia tratamiento Esteroide Vía local Alergia Conjuntiva patología Inmunopatología Queratopatía Ojo patología Segmento anterior patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02M Eye
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B09 Ophthalmology / 002B09E Diseases of cornea, anterior segment and sclera
- Discipline
- Ophthalmology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15546874
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.ophtha.2003.05.035 
https://dx.doi.org/10.1016/j.ophtha.2003.05.035
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2003.05.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"111\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"476\";s:8:\"\u0000*\u0000epage\";s:3:\"482\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AKPEK\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Esen Karamursel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:12:\"DART, John K\";i:1;s:17:\"WATSON, Stephanie\";i:2;s:17:\"CHRISTEN, William\";i:3;s:13:\"DURSUN, Dilek\";i:4;s:10:\"YOO, Sonia\";i:5;s:19:\"O'BRIEN, Terrence P\";i:6;s:16:\"SCHEIN, Oliver D\";i:7;s:15:\"GOTTSCH, John D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2003.05.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"111\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"476\";s:8:\"\u0000*\u0000epage\";s:3:\"482\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AKPEK\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Esen Karamursel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:12:\"DART, John K\";i:1;s:17:\"WATSON, Stephanie\";i:2;s:17:\"CHRISTEN, William\";i:3;s:13:\"DURSUN, Dilek\";i:4;s:10:\"YOO, Sonia\";i:5;s:19:\"O'BRIEN, Terrence P\";i:6;s:16:\"SCHEIN, Oliver D\";i:7;s:15:\"GOTTSCH, John D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2003.05.035\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2003.05.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"111\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"476\";s:8:\"\u0000*\u0000epage\";s:3:\"482\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AKPEK\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Esen Karamursel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:12:\"DART, John K\";i:1;s:17:\"WATSON, Stephanie\";i:2;s:17:\"CHRISTEN, William\";i:3;s:13:\"DURSUN, Dilek\";i:4;s:10:\"YOO, Sonia\";i:5;s:19:\"O'BRIEN, Terrence P\";i:6;s:16:\"SCHEIN, Oliver D\";i:7;s:15:\"GOTTSCH, John D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1016\/j.ophtha.2003.05.035\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:104:\"A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis\";s:9:\"\u0000*\u0000jtitle\";s:29:\"Ophthalmology (Rochester, MN)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Ophthalmology (Rochester MN)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"111\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"476\";s:8:\"\u0000*\u0000epage\";s:3:\"482\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0161-6420\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AKPEK\";s:10:\"\u0000*\u0000aufirst\";s:15:\"Esen Karamursel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:12:\"DART, John K\";i:1;s:17:\"WATSON, Stephanie\";i:2;s:17:\"CHRISTEN, William\";i:3;s:13:\"DURSUN, Dilek\";i:4;s:10:\"YOO, Sonia\";i:5;s:19:\"O'BRIEN, Terrence P\";i:6;s:16:\"SCHEIN, Oliver D\";i:7;s:15:\"GOTTSCH, John D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"OPHTDG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:104:\"A randomized trial of Topical cyclosporin 0.05% in Topical steroid-resistant atopic keratoconjunctivitis\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
